PECK Structural worked with Gilead Sciences, the US Biotech firm, and Comi Polaris, an Italian equipment supplier to confirm design and installation specifications for equipment developed under EU standards, for use in the USA.
We performed calculations for equipment and “non-building structures” to confirm seismic capacity of the structural system required to support equipment for Gilead Sciences, the maker of Remdesivir, an experimental drug showing promise as a treatment for patients with severe COVID-19 infection. Site location: La Verne, CA.